CBAY
Cymabay Therapeutics
CBAY
CBAY
Delisted
CBAY was delisted on the 21st of March, 2024.
39 hedge funds and large institutions have $65M invested in Cymabay Therapeutics in 2017 Q2 according to their latest regulatory filings, with 9 funds opening new positions, 14 increasing their positions, 7 reducing their positions, and 4 closing their positions.
Holders
39
Holders Change
+5
Holders Change %
+14.71%
% of All Funds
0.97%
Holding in Top 10
3
Holding in Top 10 Change
–
Holding in Top 10 Change %
–
% of All Funds
0.07%
New
9
Increased
14
Reduced
7
Closed
4
Calls
$32K
Puts
$3K
Net Calls
+$29K
Net Calls Change
+$29K
Top Buyers
1 |
1
Millennium Management
New York
|
$2.45M |
2 |
2
Deutsche Bank
Frankfurt Am Main Ge,
Germany
|
$1.41M |
3 |
3
Vanguard Group
Malvern,
Pennsylvania
|
$5.71M |
4 |
GTC
4
Ghost Tree Capital
New York
|
$3.74M |
5 |
IHM
5
Iguana Healthcare Management
New York
|
$605K |